Table 2.
Absolute (10–3 mm2/s) |
Relative percentage |
|||
---|---|---|---|---|
Range | Median | Range | Median | |
Per-voxel variation | ||||
Cancer ROI | [0.0, 0.84] | 0.097 | [0.0%, 67%] | 11% |
Whole prostate | [0.0, 1.6] | 0.080 | [0.0%, 200%] | 7.1% |
Per-ROI variation | ||||
Cancer ROI | [0.0, 0.46] | 0.036 | [1.0%, 38%] | 4.2% |
Mean + SD ADC of whole prostatea: 1.2 ± 0.27 × 10–3 mm2/s | ||||
Mean + SD ADC of cancersa: 0.95 ± 0.32 × 10–3 mm2/s |
Voxelwise ADC across all patients